Lucinda (Cindy) Buhse is currently the Director for the Office of Quality Surveillance (OQS) in the Office of Pharmaceutical Quality (OPQ) in the Center of Drug Evaluation and Research in the US Food and Drug administration (FDA). Dr. Buhse joined FDA in 2001 in OPQ’s Office of Testing and Research. She was Director for Office of Testing and Research from 2013 to 2017. Before joining the FDA, Dr. Buhse worked in management positions in Production, Validation and Analytical Services at Sigma Aldrich Corporation and as a Senior Research Scientist for Rohm and Haas Company. Dr. Buhse received a B.A. in Chemistry from Grinnell College and a Ph.D. in Physical Chemistry from the University of California, Berkeley. OQS assures that quality medicines are available through signal detection, data analysis, review of the state of quality and proactive stakeholder engagement.